v3.25.2
Lessor Leases
6 Months Ended
Jun. 30, 2025
Leases [Abstract]  
Lessor Leases Lessor Leases
Sales-Type Leases
The Company enters into non-cancelable sales-type lease arrangements with the leases varying in length from one to ten years. The Company optimizes cash flows by selling a majority of its sales-type leases, other than those relating to U.S. government hospitals and SaaS and Expert Services products, including Central Pharmacy Dispensing Service and IV Compounding Service, to third-party leasing finance companies on a non-recourse basis. The Company generally has no obligation to the leasing company once the lease has been sold.
The following table presents the Company’s income recognized from sales-type leases:
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
(In thousands)
Sales-type lease revenues$6,631 $11,576 $12,449 $18,612 
Cost of sales-type lease revenues(4,102)(7,110)(7,039)(11,297)
Selling profit on sales-type lease revenues$2,529 $4,466 $5,410 $7,315 
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components:
June 30,
2025
December 31,
2024
(In thousands)
Net minimum lease payments to be received$79,433 $77,976 
Less: Unearned interest income portion(12,847)(12,757)
Net investment in sales-type leases66,586 65,219 
Less: Current portion (1)
(12,629)(12,475)
Long-term investment in sales-type leases, net$53,957 $52,744 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets.
The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows:
June 30,
2025
(In thousands)
Remaining six months of 2025$8,536 
202615,310 
202714,266 
202813,176 
202910,511 
Thereafter17,634 
Total future minimum sales-type lease payments79,433 
Present value adjustment(12,847)
Total net investment in sales-type leases$66,586